About us

The website MinderMigraine.nl has been developed by the Research, Development & Prevention Department of the University of Amsterdam. This development was conducted and/or supervised by:

Frédérique E.S. Jurgens
Master student MPA at Vrije Universiteit 

Claudia M. van der Heijde
Senior researcher

Peter Vonk
General practitioner, organisational project coordinator

Daan Tempelman
General practitioner, quality coordinator 

Bas ter Meulen
Neurologist OLVG, content project coordinator

Willem Baas
Founder of the web design agency Baas interactive

UvA general practitioner office

Students of the UvA and the HvA can seek treatment at Huisartsen UvA by general practitioners with specific knowledge of student life. The practice is accessible to students from all over Amsterdam. The practice is also available to non-students, although a regional limitation applies.

Contact

The practice can be reached every working day from 08.00 to 17.00 on the following number:

Telephone during the day: 020-5252878
Emergency during the day: 020-5252889

General practitioners UvA
Oude Turfmarkt 151
1012 GC Amsterdam

www.huisartsenpraktijkUvA.nl
www.studentenartsen.nl

Sources and financial interests in this website

MinderMigraine.nl is an independent website. The information on the website is mainly obtained from the Headache Standard of the Dutch College of General Practitioners (NHG) and scientific articles.

There are no financial interests of the involved parties. There are also no (pharmaceutical) companies involved in this website, which means that the results of the test have not been influenced by companies that may benefit from migraine prevention.

The sources used for the content of the website are listed below.

Sources:

  • Marmura, M. J. (2018). Triggers, Protectors, and Predictors in Episodic Migraine. Current Pain and Headache Reports, 22(12). https://doi.org/10.1007/s11916-018-0734-0
  • Todd, C., Lagman-Bartolome, A. M., & Lay, C. (2018). Women and Migraine: the Role of Hormones. Current Neurology and Neuroscience Reports, 18(7). https://doi.org/10.1007/s11910-018-0845-3
  • Giraud, P., & Chauvet, S. (2013). Migraine and obesity, is there a link? Revue Neurologique, 169(5), 413–418. https://doi.org/10.1016/j.neurol.2012.11.009
  • Farooque, U., Okorie, N., Kataria, S., Shah, S. F., & Bollampally, V. C. (2020). Cocaine-Induced Headache: A Review of Pathogenesis, Presentation, Diagnosis, and Management. Cureus. https://doi.org/10.7759/cureus.10128
  • Martin, L. F., Patwardhan, A. M., Jain, S. V., Salloum, M. M., Freeman, J., Khanna, R., Gannala, P., Goel, V., Jones-MacFarland, F. N., Killgore, W. D., Porreca, F., & Ibrahim, M. M. (2020). Evaluation of green light exposure on headache frequency and quality of life in migraine patients: A preliminary one-way cross-over clinical trial. Cephalalgia, 41(2), 135–147. https://doi.org/10.1177/0333102420956711
  • Sun-Edelstein, C., & Mauskop, A. (2009). Foods and Supplements in the Management of Migraine Headaches. The Clinical Journal of Pain, 25(5), 446–452. https://doi.org/10.1097/ajp.0b013e31819a6f65
  • Derry, S., Moore, R. A., & McQuay, H. J. (2010). Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd008040.pub2
  • Kubik, S. U., & Martin, P. R. (2016). The Headache Triggers Sensitivity and Avoidance Questionnaire: Establishing the Psychometric Properties of the Questionnaire. Headache: The Journal of Head and Face Pain, 57(2), 236–254. https://doi.org/10.1111/head.12940
  • Stewart, W. F., Lipton, R. B., Dowson, A. J., & Sawyer, J. (2001). Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology, 56(Supplement 1), S20–S28. https://doi.org/10.1212/wnl.56.suppl_1.s20
  • Peikert, A., Wilimzig, C., & Köhne-Volland, R. (1996). Prophylaxis of Migraine with Oral Magnesium: Results From A Prospective, Multi-Center, Placebo-Controlled and Double-Blind Randomized Study. Cephalalgia, 16(4), 257–263. https://doi.org/10.1046/j.1468-2982.1996.1604257.x
  • Gaul, C., Diener, H. C., & Danesch, U. (2015). Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. The Journal of Headache and Pain, 16(1). https://doi.org/10.1186/s10194-015-0516-6
  • Grossmann, M., & Schmidramsl, H. (2000). An extract of Petasites hybridus is effective in the prophylaxis of migraine. Int. Journal of Clinical Pharmacology and Therapeutics, 38(09), 430–435. https://doi.org/10.5414/cpp38430